Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
6 Resultado(s)
Ensayo clínico en reclutamiento
= 
; Ensayos clínico en curso
= 
; Financiado por un miembro del IRDiRC = 
; Miembro de una ERN = 
Ensayo(s) clínico(s) nacional(es)
ALEMANIA
Nordrhein-Westfalen
ESSEN
STREAM - A randomized discontinuation, blinded, placebo-controlled phase II study of Sorafenib in patients with chemonaive metastatic Uveal Melanoma
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)
ALEMANIA
Nordrhein-Westfalen
ESSEN
CREATE: Cross-tumoral Phase 2 clinical trial exploring Crizotinib (PF-02341066) in patients with advanced tumor induced by causal alterations of ALK and/or MET - DE
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)
ALEMANIA
Nordrhein-Westfalen
ESSEN
POETIG: Phase 2 Trial of Ponatinib in Patients with Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) Following Failure or Intolerance of Prior Therapy with Imatinib - DE
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)
ALEMANIA
Nordrhein-Westfalen
ESSEN
OPTIM: A Randomized Phase II Study on the OPTimization of IMmunotherapy in Squamous Carcinoma of the Head and Neck
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)
ALEMANIA
Nordrhein-Westfalen
ESSEN
PONS: Phase 2 Clinical Trial with Ponatinib as a Second Line Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to prior First Line Tyrosine Kinase Inhibitor Treatment
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)
ALEMANIA
Nordrhein-Westfalen
ESSEN